SCHEMBL4839015

SCHEMBL4839015

O=C(O)Cc1cccc(CCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccccc3C(F)(F)F)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.39
PSEN2 P49810 1/20 0.39
APH1B Q8WW43 1/20 0.39
NCSTN Q92542 1/20 0.39
APH1A Q96BI3 1/20 0.39
PSENEN Q9NZ42 1/20 0.39
SCN9A Q15858 1/20 0.38
FKBP1A P62942 1/20 0.37
FFAR1 O14842 1/20 0.37
PTGER3 P43115 1/20 0.37
MMP8 P22894 5/20 0.37
MMP3 P08254 3/20 0.37
MAPK1 P28482 2/20 0.36
SLC13A5 Q86YT5 1/20 0.36
GAA P10253 1/20 0.36
ALDH1A1 P00352 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4841347 0.93 SLC13A5 (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4838060 0.91 PTPN1 (0.39) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4845363 0.88 RORC (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4832648 0.87 SCN9A (0.48) SCN9AFKBP1APTGER3MMP8MMP3
SCHEMBL4845199 0.85 FFAR4 (0.44) SCN9AFFAR1PTGER3MMP8MMP3
SCHEMBL4842900 0.85 FFAR4 (0.43) SCN9APTGER3MMP8MMP3MAPK1
SCHEMBL4842772 0.84 PPARD (0.37) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4841693 0.84 FFAR4 (0.43) SCN9APTGER3MMP8MMP3MAPK1
SCHEMBL4034006 0.84 MMP1 (0.40) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4841713 0.84 SCN9A (0.39) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 PSEN1 100/4885PSEN2 309/4885APH1B 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.